In situ expression of ERG protein in the context of tumor heterogeneity identifies prostate cancer patients with inferior prognosis

In situ expression of ERG protein in the context of tumor heterogeneity identifies prostate cancer patients with inferior prognosis

Prognostic biomarkers for prostate cancer are needed to improve prediction of disease course and guide treatment decisions. However, biomarker development is complicated by the common multifocality and heterogeneity of the disease. We aimed to determine the prognostic value of candidate biomarkers t...

Full description

Bibliographic Details
Main Authors: Susanne G. Kidd, Mari Bogaard, Kristina T. Carm, Anne Cathrine Bakken, Aase M. V. Maltau, Marthe Løvf, Ragnhild A. Lothe, Karol Axcrona, Ulrika Axcrona, Rolf I. Skotheim
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:Molecular Oncology
Subjects:
biomarker
ERG
ETS
heterogeneity
prognosis
prostate cancer
Online Access:https://doi.org/10.1002/1878-0261.13225

Internet

https://doi.org/10.1002/1878-0261.13225

Similar Items